Anna M. Grawenda

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index891citations32works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(15), Cancer-related Molecular Pathways(9), Sarcoma Diagnosis and Treatment(7), Epigenetics and DNA Methylation(6), Hippo pathway signaling and YAP/TAZ(6)

Publications32 total

Data from A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
2023Open Access
Supplementary Tables 1-6 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figure 3 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figure 3 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figure 2 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Methods, Figure Legends 1-3, Table Legends 1-6 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figures 1-5, Table 1 from A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
2023Open Access
Supplementary Tables 1-6 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Data from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figure 1 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figures 1-5, Table 1 from A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
2023Open Access
Supplementary Methods, Figure Legends 1-3, Table Legends 1-6 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Data from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figure 2 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Supplementary Figure 1 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
2023Open Access
Data from A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
2023Open Access
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis
The EMBO Journal·2021· 25 citedOpen Access
RASSF1C oncogene elicits amoeboid invasion, cancer stemness and invasive EVs via a novel SRC/Rho axis
2021· 1 citedOpen Access
RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73
Nature Communications·2018· 100 citedOpen Access
Polymorphisms in the p53 pathway are enriched in cancer susceptibility loci and share characteristics with somatic pathway mutations
European Journal of Cancer·2016
page 1 of 2Next →

Frequent Co-authors

Gareth L. Bond(21), Lukasz F. Grochola(18), Helge Täubert(18), Amina F.A.S. Teunisse(14), Emmanouela Repapi(14), Eric O’Neill(13), Kristiaan Lenos(13), Kirsten Lodder(13), Marieke L. Kuijjer(13), Frank Bartel(13), Pancras C.W. Hogendoorn(13), Peter Wuerl(13), Anne‐Marie Cleton-Jansen(13), Aart G. Jochemsen(11), Garth Hamilton(9), Karen S. Yee(8), Dafni‐Eleftheria Pefani(5), Nikola Vlahov(5), Elisabeth E. Bond(5), Peter Würl(5)